^
CANCER:
Tenosynovial Giant Cell Tumor
No biomarker
|
Tenosynovial Giant Cell Tumor
|
No biomarker
|
Tenosynovial Giant Cell Tumor
|
pexidartinib Sensitive: A1 - Approval
|
pexidartinib Sensitive: A1 - Approval
|
No biomarker
|
Tenosynovial Giant Cell Tumor
|
No biomarker
|
Tenosynovial Giant Cell Tumor
|
nilotinib Sensitive: A2 - Guideline
|
nilotinib Sensitive: A2 - Guideline
|
COL6A3-CSF1 fusion
|
Tenosynovial Giant Cell Tumor
|
COL6A3-CSF1 fusion
|
Tenosynovial Giant Cell Tumor
|
gefitinib + mitoxantrone Sensitive: C4 – Case Studies
|
gefitinib + mitoxantrone Sensitive: C4 – Case Studies
|
